Four-year-old Orion Qurbonaliev is lucky to be alive. Just last February, the little boy was lying comatose in the tuberculosis ward of a hospital in southern Tajikistan. The bacteria had spread to his spine and paralyzed the right side of his body. He was severely dehydrated and malnourished.
The staff on the government-run ward had run out of options for treating Orion. "They just left this kid to die," says Tina Martin, a nurse with Doctors Without Borders.
Forms of tuberculosis are emerging that are costly, difficult and at times, nearly impossible to treat. This new, worldwide threat is called multidrug-resistant TB, and it occurs when the bacteria no longer respond to the most common TB medications. Doctors have to turn, instead, to older, less effective drugs that can have devastating side effects such as hearing loss, blindness, aches and severe depression.
Oxana and Pavel Rucsineanu fell in love under the drug-induced haze of powerful tuberculosis medications. It was the summer of 2008. They were both in their late 20s, and they should have been in the prime of their lives.